Radiation therapy in prostate cancer: a risk-adapted strategy.
about
Prostate cancer: current treatment and prevention strategies.Hemiablative Focal Low Dose Rate Brachytherapy: A Phase II Trial Protocol.Cyclin D1 silencing suppresses tumorigenicity, impairs DNA double strand break repair and thus radiosensitizes androgen-independent prostate cancer cells to DNA damage.Management of Localized Prostate Cancer by Focal Transurethral Resection of Prostate Cancer: An Application of Radical TUR-PCa to Focal Therapy.Tumor-associated autoantibodies correlate with poor outcome in prostate cancer patients treated with androgen deprivation and external beam radiation therapy
P2860
Radiation therapy in prostate cancer: a risk-adapted strategy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Radiation therapy in prostate cancer: a risk-adapted strategy.
@ast
Radiation therapy in prostate cancer: a risk-adapted strategy.
@en
Radiation therapy in prostate cancer: a risk-adapted strategy.
@nl
type
label
Radiation therapy in prostate cancer: a risk-adapted strategy.
@ast
Radiation therapy in prostate cancer: a risk-adapted strategy.
@en
Radiation therapy in prostate cancer: a risk-adapted strategy.
@nl
prefLabel
Radiation therapy in prostate cancer: a risk-adapted strategy.
@ast
Radiation therapy in prostate cancer: a risk-adapted strategy.
@en
Radiation therapy in prostate cancer: a risk-adapted strategy.
@nl
P2093
P2860
P1433
P1476
Radiation therapy in prostate cancer: a risk-adapted strategy.
@en
P2093
P2860
P304
P478
17 Suppl 2
P577
2010-09-01T00:00:00Z